Vico Therapeutics International SRL
Vico Therapeutics International reported total assets of €87.9m at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jul 2026).
By total assets for 2025, Vico Therapeutics International ranks among the 1,000 largest of the 24,102 companies in its sector (NACE 6421) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Vico Therapeutics International shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +229 % Total assets +106 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Vico Therapeutics International's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jul 2026
- Year ended 31 Dec 2024filed on 17 Jul 2025
- Year ended 31 Dec 2023filed on 08 Oct 2024
- Year ended 31 Dec 2022filed on 25 Oct 2023
- Year ended 31 Dec 2021filed on 07 Jul 2022
Vico Therapeutics International's financial analysis
- Solvency99.8%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Vico Therapeutics International
12 active director(s) in the register.
and 6 more
Vico Therapeutics International's shareholders and holdings →Vico Therapeutics International's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0746.929.395
- VAT number
- No VAT activity declared to the CBE
- Peppol
- Registered · 0208:0746929395 · as of 11 Nov 2026
- Legal form
- SRL
- Incorporated
- 15 May 2020
- Registered office
- 1930 Zaventem
- Latest accounts
- 2025 · filed on 30 Jul 2026
- Activity
- Activities of holding companies (NACE 64210)
Vico Therapeutics International (SRL) has been based in Zaventem since 2020, active in: activities of holding companies. For 2025, it reports a net loss of 356,083 € and equity of €87.7m; its revenue is not published. Its solvency stands at 99.8%, above the median of its sector (55.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Vico Therapeutics International
Companies in the same business, of comparable size and area, outside its group.
- Carmeuse Impact Other activities auxiliary to financial services, except insurance and pension funding Ottignies-Louvain-la-Neuve · balance sheet €76.1m
- Aminter N.V. Activities of holding companies Ixelles · balance sheet €67.8m
- ittak Activities of head offices Destelbergen · balance sheet €108.2m
- Santé Finance et Investissements Activities of holding companies Uccle · balance sheet €59.7m
- TrustCapital Activities of holding companies Kortrijk · balance sheet €132.7m
- Indufin Investment Fund Activities of holding companies Dilbeek · balance sheet €57.7m
- AbrisoJiffy Invest Activities of holding companies Anzegem · balance sheet €135.9m
- 2Erebus4 Brussels · balance sheet €56.6m
Frequently asked questions about Vico Therapeutics International
What is the revenue of Vico Therapeutics International?
Vico Therapeutics International files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Vico Therapeutics International?
According to the Crossroads Bank for Enterprises, no VAT-liable activity is declared for Vico Therapeutics International. If it is VAT-registered, its VAT number is its company number prefixed with BE: BE0746929395. Its company number (CBE) is 0746.929.395.
Where is the registered office of Vico Therapeutics International?
According to the CBE register, the registered office of Vico Therapeutics International is in 1930 Zaventem.
What is the equity of Vico Therapeutics International?
At the close of the 2025 financial year, the equity of Vico Therapeutics International amounts to 87,728,331 €, a solvency of 99.8% of total assets.
Who manages Vico Therapeutics International?
The register lists 12 active mandates at Vico Therapeutics International. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Vico Therapeutics International within its sector?
By total assets for 2025, Vico Therapeutics International ranks among the 1,000 largest of the 24,102 companies in its sector (NACE 6421) in Belgium that filed accounts for that financial year.
The full file of Vico Therapeutics International
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →